Dr. Tarek A. Elshaarawy, MD

Dr. Elshaarawy practices at Vascular Health Center in Battle Creek, Michigan.

Dr. Elshaarawy's NPI, 1982676110, was assigned on February 2, 2006. Dr. Elshaarawy holds Michigan license 4301089405.

Dr. Elshaarawy's primary practice is Vascular Health Center, at 3790 Capital Ave Sw, Battle Creek, MI 49015-8332. The practice phone is (269) 979-6310.

Dr. Elshaarawy's primary practice is Vascular Health Center in Battle Creek, Michigan. Dr. Elshaarawy is also affiliated with Bronson Battle Creek Hospital. The medical group on file is Vascular Health Center. Dmand AI also links Dr. Elshaarawy to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elshaarawy practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Elshaarawy's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Elshaarawy's licenses on file in 2 states: Michigan and New Jersey.

CMS data shows 4,407 Medicare services from Dr. Elshaarawy across 23 procedure codes in 2024, for 654 Medicare patients. Medicare paid $1,318,528 for them. Every service was in an office.

CMS counts 654 Medicare patients who saw Dr. Elshaarawy in 2024. The largest group is 65 to 74, with 249 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elshaarawy's median patient age at 73, with 56% women.

In 2024, Dr. Elshaarawy wrote 626 Medicare Part D claims for 183 patients. 77% of them were for generic drugs. CMS names the drug for 538 of them, across 4 drugs with 11 or more claims each, at $145,852 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Elshaarawy for performance year 2024, reported individually. Dr. Elshaarawy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 180 procedures of leg revascularization (restoring blood flow) by Dr. Elshaarawy, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 40 general payments to Dr. Elshaarawy from 18 drug and device companies from 2024 to 2025. Device or supply loans make up the largest share, 94% of the total. AngioDynamics, Inc. paid the most, $16,808.